CURRICULUM VITAE

Karen Elizabeth Doucette, MD, MSc, FRCPC

Office AddressUniversity of 11350-83 Avenue 1-139 CSBEdmonton, Alberta CANADAT6G 2G6Phone (780) 492-7686Fax (780) 492-8050Pager (780) 445-3277e-mail: karen.doucette@ualberta.ca

CURRENT POSITIONSMay 2015 Divisional Director, Division of Infectious Disease, Department of Medicine,

University of Alberta, Edmonton, Alberta, Canada

May 2015 Section Chief of Infectious DiseasesAlberta Health Services, Edmonton Zone

2010 Associate Professor, Department of Medicine, Division of Infectious Diseases, University of Alberta, Edmonton, Alberta, Canada

2008 Education Director, Transplant Infectious Diseases Fellowship, University of Alberta, Edmonton, Alberta, Canada

EDUCATIONDegrees2007 Masters of Science (Epidemiology),

Harvard School of Public Health, Boston, Massachusetts, USA

2003 Certificate, Summer Program in Clinical EffectivenessHarvard School of Public Health, Boston, Massachusetts, USA

1996 Doctor of MedicineDalhousie University, Halifax, Nova Scotia, Canada

1992 Bachelor of Science (Biology)Dalhousie University, Halifax, Nova Scotia, Canada

Fellowships2003-2004 Research and Clinical Fellow, Transplant Infectious Diseases

Massachusetts General Hospital, Boston, Massachusetts, USARevised: April 2016

1

1999-2001 Infectious Diseases FellowshipUniversity of Manitoba, Winnipeg, Manitoba, Canada

1996-1999 Internal Medicine ResidencyQueen’s University, Kingston, Ontario, Canada

Licences and Professional Qualifications2012 Certification, Utilization of FibroScan® 502

2004 Registered Member, College of Physicians and Surgeons of Alberta

2001 Certificate, Infectious Diseases, Royal College of Physicians and Surgeons of Canada

1999-2001 Registered Member, College of Physicians and Surgeons of Manitoba

1999 Fellow, Internal Medicine, Royal College of Physicians and Surgeons of Canada

1997 Licentiate, Medical Council of Canada

HONORS & AWARDS2016 Fellow of the American Society of Transplantation (FAST)

FAST designation recognizes AST members who have demonstrated both an exceptional commitment to the field of transplantation and outstanding service to the AST.

2011 Cooperation, Collaboration and Teamwork Award (Hepatitis Support Program)

2010 Cooperation, Collaboration and Teamwork Award (Transplant ID)

2002 R. Samuel McLaughlin Research and Education Fellowship Award ($50 000)University of Manitoba/Manitoba Medical Service FoundationAwarded to residents who have completed residency training and are wishing financial support to fund further medical fellowship training in research or medical education deemed useful to the University. To support training in Transplant Infectious Diseases

2002 Faculty Development Fund ($50 000)Department of Medicine, University of ManitobaTo support training in Transplant Infectious Diseases

1999 Grand Prize, Best Resident Grand Rounds“Antiretroviral Therapy for HIV Infection”Queen’s University, Kingston, Ontario, Canada

Revised: April 2016

2

1999 Second Prize, Resident Research Day“Outpatient Antibiotic Therapy for Endocarditis: A Cost Minimization

Analysis”.Queen’s University, Kingston, Ontario, Canada

1995 Department of Surgery PrizeHighest Mark in Surgery ExaminationDalhousie University, Halifax, Nova Scotia, Canada

1994 University ScholarshipHigh Academic StandingDalhousie University, Halifax, Nova Scotia, Canada

1994 Dr. J.V. Graham AwardHigh Standing in Anatomy - Med I & Med IIDalhousie University, Halifax, Nova Scotia, Canada

1993 Professor D.L. Cameron PrizeHighest Standing in Anatomy - Med IDalhousie University, Halifax, Nova Scotia, Canada

1991 Joseph Duncan ScholarshipAcademic AchievementDalhousie University, Halifax, Nova Scotia, Canada

PREVIOUS PROFESSIONAL/ACADEMIC POSITIONS HELD11/2006-05/2015 Infectious Diseases Medical Director, Hepatitis Support Program,

Edmonton, Alberta, Canada

01/2004-06/2010 Assistant Professor, Department of Medicine, Division of Infectious Diseases, University of Alberta, Edmonton, Alberta, Canada

02/2002-06/2002 Lecturer, Department of Internal Medicine, University of Manitoba, Winnipeg, Manitoba, Canada

07/2001-12/2002 Associate Physician, Department of Medicine, Section of Hepatology, Winnipeg Regional Health AuthorityInfectious Diseases Consultant, Viral Hepatitis Investigative Unit, Winnipeg Health Sciences Centre

PROFESSIONAL ASSOCIATION MEMBERSHIPSAlberta Medical AssociationCanadian Medical AssociationAssociation of Medical Microbiology & Infectious Diseases of CanadaAmerican Association for the Study of Liver Diseases Canadian Association for the Study of the LiverCanadian Society of TransplantationAmerican Society of Transplantation (AST)

Revised: April 2016

3

AST Infectious Diseases Community of Practice Transplantation SocietyAFC Committee in Solid Organ TransplantationInternational Society For Heart And Lung Transplantation

RESEARCHInvited Presentations02/19/2016 HCV in End Stage Renal Disease and Transplantation

Nephrology Rounds, University of AlbertaEdmonton, AB

01/22/2016 Viral hepatitis in Refugees Vodcasthttps://ualberta.mediacore.tv/media/hepatitis/embed_player?embed_token=-rl9CHmVwgallMqoBCKJ0_quzhQ9BJPmPqQD_G8N96FtKKfvI8rgkzfLd-6J7VM62yTYlim5m9ueC9QU_R0rnAEdmonton, AB

11/14/2015 Infection in the Post-Transplant PatientRocky Mountain/ACP Internal Medicine ConferenceBanff, Alberta

09/26/2015 The Success of Hepatitis C Therapies and the Challenges of HCV Elimination

Alberta Society of Infectious Diseases Annual MeetingBanff, Alberta

04/18/2015 Addressing Unmet Medical Needs in HCV Genotype 3Association of Medical Microbiology and Infectious Diseases Canada Annual MeetingCharlottetown, PEI

07/26/2014 Tuberculosis in Transplantation World Transplant Congress Pre-Meeting Symposium SessionSan Francisco, California, USA

27/09/2013 Targeted Liver AssessmentAlberta Hepatology Nurses Association Annual MeetingEdmonton, AB

22/09/2013 EBV and PTLD in TransplantationCanadian Transplant Fellows SymposiumToronto, ON

2013/05/20 Tuberculosis in TransplantationAmerican Transplant Congress, Symposium SessionSeattle, Washington, USA

17/07/2012 Hepatitis B and HIV Co-InfectionInner City Medicine Update

Revised: April 2016

4

Winnipeg, MB

07/06/2012 Donor Derived Infectious Disease Transmission: Epidemiology and Risk Reduction

Combined Infectious Diseases and Nephrology RoundsHalifax, NS

07/06/2012 Update on Management of CMV in Organ TransplantationMulti-organ Transplant RoundsHalifax, NS

17/09/2011 EBV and PTLD in TransplantationCanadian Transplant Fellows SymposiumToronto, ON

15/09/2010 Hepatitis B UpdateHepatitis Support ProgramEdmonton, AB

11/06/2010 Donor Derived Infectious Epidemiology and Risk ReductionBC Transplant DayVancouver, BC

11/06/2010 CMV in Renal TransplantBC Transplant DayVancouver, BC

09/06/2010 Infectious Disease screening of the organ donor: Balancing Risks of Transmission with Wait List MortalityAlberta Transplant Lecture SeriesEdmonton, AB

08/05/2010 ABC of Transplantation Infectious DiseaseAssociation of Medical Microbiology and Infectious DiseaseEdmonton, AB

04/05/2010 CMV Ag vs PCRAmerican Transplant CongressSan Diego, CA

01/05/2010 Nontuberculous Mycobacteria in Solid Organ TransplantAmerican Transplant CongressSan Diego, CA

14/04/2010 HBV-Interpretation of Hepatitis B serological test results and treatment options of those with acute and chronic hepatitis B infectionsCorrections CanadaEdmonton, AB

26/03/2010 EBV/PTLDRevised: April 2016

5

Western Canada Multidisciplinary Pediatric Cardiac RoundsEdmonton, AB

17/10/2009 Epstein-Barr Virus and PTLD Canadian Transplant Fellows SymposiumToronto, ON

17/10/2009 Cytomegalovirus PreventionCanadian Transplant Fellows SymposiumToronto, ON

05/06/2009Infection and PTLD Pediatric Heart Transplant Boot Camp Edmonton, AB

15/05/2009CMV and EBV in SOT: What’s New in Prevention and Treatment Manitoba Transplant RoundsWinnipeg, MB

26/05/2009Candidiasis Guideline Review Infectious Diseases Residents Development Day Edmonton, AB

08/04/2009Hepatitis B in Canada Canadian Liver Foundation: Living with Liver Disease Speaker SeriesEdmonton, AB

28/01/2009Update on HCV and HBV from AASLDEdmonton, AB

25/02/2008Update on CMV Prevention and Treatment International Transplant Nurses SocietyToronto, ON

12/12/2007Viral Infections in Non Renal Organ Transplant Transplant Rounds Saskatoon, SK

25/11/2007HBV Therapy: Implications of ResistanceCanadian Liver Transplant ForumToronto, ON

13/10/2007EBV and Posttransplant Lymphoproliferative DisorderCanadian Transplant Fellows SymposiumToronto, ON

05/05/2007Approach to Fever in the Solid Organ Transplant RecipientAmerican Transplant Congress, Pre-meeting SymposiumSan Francisco, CA

Revised: April 2016

6

15/03/2007Hepatitis C in Lung Transplant: What Should We Be doing in Canada?Canadian Lung Transplant Study Group Annual MeetingBanff, AB

03/05/2006Update on Hepatitis C Management Grey Nuns Hospital Grand Medical RoundsEdmonton, AB

22/04/2006New Frontiers in Antifungal TherapyCanadian Blood and Marrow Transplant Group Annual Meeting Sunrise Symposium Edmonton, AB

31/03/2006Cytomegalovirus in Organ TransplantationSouthern Alberta Transplant Rounds (ALTRA)University of Calgary, Calgary, AB

23/03/2006Tuberculosis in Solid Organ TransplantTuberculosis the Edge of Change: What’s New in an Old Disease (Annual Western Canadian Conference on Tuberculosis Care) Edmonton, AB

15/03/2006Post Residency Training Trainees DayAssociation of Medical Microbiology and Infectious Diseases (Canada) Annual Meeting Victoria, B.C.

01/03/2006Emerging Infections in Solid Organ TransplantCanadian Association of Transplantation Annual MeetingMt. Tremblant, PQ

23/10/2004Emerging Infections in TransplantationWestern Canada Infectious Disease ConferenceKananaskis, AB

25/02/2004Emerging Infections in TransplantationDepartment of Medicine Grand RoundsUniversity of Saskatchewan Saskatoon, SK

25/02/2004Infections in Solid Organ TransplantationInternal Medicine Resident RoundsUniversity of Saskatchewan Saskatoon, SK

9/11/2003 HBV/HCV Co-infection and HBV in Special SituationsCanadian Consensus Conference on the Management of Viral HepatitisOttawa, ON

Revised: April 2016

7

06/03/2003Treatment of HCV and HIV/HCV Co-infectionCanadian Infectious Disease Society Annual MeetingQuebec City, PQ

07/06/2002Hepatitis C and HIV Co-InfectionCanadian Hemophilia Society Annual Meeting Saskatoon, SK

05/03/2002What’s New in Hepatitis C Treatment Partners in Caring ConferenceHealth Canada and Correctional Services CanadaWinnipeg, MB

28/02/2002Liver Transplantation in HIV/HCV Co-infected IndividualsCanadian Infectious Disease Society Annual MeetingBanff, AB

Grants2015 Public Health Agency of Canada (PHAC) & Nova Scotia Health Research

Foundation ($200,000)Co-investigator University of Alberta Evidence Review Synthesis CentreMultiple evidence reviews for PHAC

2013 Pfizer Canada (15 000)Principal InvestigatorIncidence and Risk Factors for Enterococcal Infection Early Post-Liver

Transplant

2010 Roche Canada ($14 000)Principal Investigator Molecular Diagnostic Testing of Patients with Chronic Hepatitis B Virus (HBV): HBV Genotyping and HBsAg Titre Quantification

2006 University Hospital Foundation ($21 384)Principal InvestigatorCommunity Acquired Respiratory Virus infections following lung transplantation: Molecular epidemiology and association with bronchiolitis obliterans

2006 Roche Canada Research Grant ($45 000)Principal InvestigatorQuantitative CMV and HHV-6 viral load in BAL samples of lung transplant recipients and association with bronchiolitis obliterans

2006 Roche Canada Research Grant ($11 800)Principal InvestigatorAn Assessment of Change from Antigenemia to CMV-PCR for Diagnosis and Surveillance of CMV in a Multiorgan Transplant program

2005 Roche Canada Research Grant ($80 000)Co-Investigator

Revised: April 2016

8

CMV Infection in Solid Organ Transplant Recipients: Cellular Immune Response and Viral Interactions

2004 Astellas Research Grant ($20 000)Principal InvestigatorBK Polyomavirus and Renal Failure in Non-Renal Solid Organ Transplant Recipients: A Case Control Study

2004 Astellas Research Grant ($65 000)Co-investigatorProspective monitoring for BKV nephropathy in recipients of kidney or combined kidney-pancreas transplants

Reviewer2016 Abstract Reviewer for

2016 The Transplantation Society Congress (Hong Kong)

2008-current Ad-hoc reviewer for American Journal of Transplantation, Clinical Transplantation, Transplant International, Clinical Infectious Diseases, Canadian Journal of Gastroenterology, Transplant Infectious Diseases, Liver Transplantation, World Journal of Gastroenterology, Canadian Journal of Infectious Diseases and Medical Microbiology

2014 Ad-hoc grant reviewer forRoche Organ Transplantation Research Foundation

2009-current Abstract Reviewer American Transplant Congress

2009 Reviewer for Canadian Society of Transplantation Kidney Disease Improving Global Outcomes (KDIGO) Clinical practice guideline for the care of kidney transplant recipients

Chapter 12 (Vaccination), 13 (Viral Diseases) and 14 (Other Infections)

2009 Reviewer for 2nd Edition- AST Transplant ID Guidelines

BK Virus Resistant gram positive bacteria

2008 Manuscript reviewer forThe Canadian Journal of Gastroenterology (2)Transplant International (2)American Journal of Transplantation (6)

2007 Manuscript reviewer forFrontiers in Bioscience [1]Transplant International [1]Canadian Journal of Gastroenterology [2]

Revised: April 2016

9

American Journal of Transplantation [4]Clinical Infectious Diseases [1]

2006 Manuscript reviewer forAmerican Journal of Transplantation [5]Clinical Infectious diseases [1]

2006 Grant reviewer forThe Physicians Services Incorporated Services (Ontario)

2005 Manuscript reviewer for American Journal of Transplantation [4]

2005 ReviewerThe Immunocompromised Traveller Committee to Advise on Tropical Medicine and Travel (CATMAT), Public Health Agency of Canada

2005 ReviewerB-Lactams, First edition Drugs and DrugsUniversity of Alberta

2004 Manuscript reviewer forAmerican Journal of Transplantation [4]Expert Reviews in Anti-Infective Therapy [1]

PUBLICATIONSPeer Reviewed Manuscripts

1. Doucette K, Preiksaitis J, Plitt S, Mabilangan C, Lee B, et al. Hepatitis B and C Serologic Profiles of Canadian Organ Donors and Recipients: Retrospective 10 Year Review at a Single Center. Transplant Infectious Disease. In Press 2016.

2. Doucette K, Weinkauf J, Kapasi A, Lien D, Halloran K. Outcomes of Lung Transplantation in Recipients with Hepatitis C Virus Infection. American Journal of Transplantation. In Press 2016.

3. Berenger B, Doucette K, Smith S. Epidemiology and risk factors for nosocomial bloodstream infections in solid organ transplants over a 10-year period. Transplant Infectious Diseases. Transplant Infectious Diseases 2016;18:183-190.

4. Doucette K, Sumner S, Weinkauf J. Treatment of Hepatitis C in a lung transplant recipient with sofosbuvir and daclatasvir. The Journal of Heart and Lung Transplantation. Feb 8, 2016. PMID: 26944671

5. Cleary S, Doucette K, Doig C, Coffin C, Grant D, et al. Canadian Association of General Surgeons position statement: recommendations for surgeons with blood-borne communicable diseases. Can J Surg 2016;59(1):7615.

Revised: April 2016

10

6. Belga S and Doucette K. Hepatitis C in Non-Hepatic Solid Organ Transplant Candidates and Recipients: A New Horizon. World Journal of Gastroenterology 2016;22(4):1650-1663.

7. Pittman C, Plitt S, Birse T, Doucette K, Romanowski B, Cooper R, et al. Prevalence and correlates of HIV and Hepatitis B Virus co-infection in Northern Alberta. Can J Infect Dis and Med Microbiol 2014;25(1):e8-e13.

8. Congly SE, Doucette KE, Coffin CS. Outcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantation. World Journal of Gastroenterology 2014;20(2):414-424.

9. O'Brien M, McHattie J, Paul H, Didi E, Worobetz L, Doucette K, et al. Treatment of Chronic Hepatitis C in a Canadian Aboriginal Population: Results from the PRAIRIE Study. Canadian Journal of Gastroenterology 2013;27(12): 707-710.

10. Congly S, Wong P, Al-Busafi S, Doucette K, Fung S, Gali P, et al. Characterization of Hepatitis B Virus Genotypes and Quantitative Hepatitis B Surface Antigen Titres in North American Tertiary Referral Liver Centres. Liver International 2013;33(9):1363-1369.

11. Weinkauf J, Puttagunta L, Nador R, Jackson K, LaBranche K, Kapasi A, et al. Long-Term Outcome of Lung Transplantation in Previous Intravenous Drug Users with Talc Lung Granulomatosis. Transplantation Proceedings 2013;45(6):2375-2377.

12. Doucette K, Al-Saif M, Kneteman N, Chui L, Tyrrell GJ, Kumar D, et al. Donor-Derived Bacteremia in liver Transplant Recipients Despite Antibiotic Prophylaxis. American Journal of Transplantation 2013;13(4):1080-1083.

13. Robinson J and Doucette K. The natural history of hepatitis C virus infection acquired during childhood. Liver International 2012;32(2):258–270.

14. Tandon P, Doucette K, Fassbender K, Vandermeer B, Durec T, Dryden DM. Granulocyte colony-stimulating factor for hepatitis C therapy-associated neutropenia: systematic review and economic evaluation. Journal of Viral Hepatitis 2011;18(7):e381-e393.

15. Avery R, Clauss H, Danziger-Isakov L, Davis J, Doucette K, van Duin D, et al. Recommended curriculum for subspecialty training in transplant infectious disease on behalf of the American Society of Transplantation Infectious Diseases Community of practice Educational Initiatives Working Group. Transpl Infect Dis 2010;12(3):190-194.

16. Hu J, Doucette K, Hartling L, Tjosvold L, Robinson J. Treatment of Hepatitis C in Children: A Systematic Review. PLoS ONE 2010; 5(7): e11542.

17. Kumar D, Husain S, Hong Chen M, Moussa G, Himsworth D, Manuel O, et al. A Prospective Molecular Surveillance Study Evaluating the Clinical

Revised: April 2016

11

Impact of Community-Acquired Respiratory Viruses in Lung Transplant Recipients. Transplantation 2010;89(8):1028-1033.

18. Levitsky J, Doucette K, and the AST Infectious Diseases Community of Practices. Viral Hepatitis in Solid Organ Transplant Recipients. American Journal of Transplantation 2009;9(Suppl 4):S116-S130.

19. Kumar D, Husain S, Moussa G, Doucette K, Manuel O, Weinkauf J, et al. A Prospective Molecular Surveillance Study Evaluating the Clinical Impact of Community Acquired Respiratory Viruses in Lung Transplant Recipients. Transplantation 2010;89(8):1028-1033.

20. Doucette K, Robson V, Shafran SD, Kunimoto D, Division of Infectious Diseases; Hepatitis Support Program, University of Alberta, Edmonton, AB. Self Referral to a Hepatitis C Clinic. Can J. Gastroenterology 2009;23(6):421-424.

21. Manuel O, Pang X, Humar A, Kumar D, Doucette K, Preiksaitis JK. An Assessment of Donor-to-Recipient Transmission Patterns of Human Cytomegalovirus by Analysis Viral Genomic Variants. Journal of Infectious Diseases. 2009;199(11):1621-1628.

22. Mason AL, Doucette K, Ka-Shu Wong G. Metagenomics and the Case of the Deadly Hamster. Hepatology 2008;48(2):679-683.

23. Gourishankar S, Doucette K, Fenton J, Purych D, Kowalewska-Grochowska K, Preiksaitis J. The use of donor and recipient screening for toxoplasma in the era of universal trimethoprim sulfamethoxazole phophylaxis. Transplantation 2008;85(7):980-985.

24. Doucette KE, Pang XL, Jackson K, Burton I, Carbonneau M, Cockfield S, et al. Prospective monitoring of BK polyomavirus infection early post-transplantation in nonrenal solid organ transplant recipients. Transplantation 2008;85(12):1733-1736.

25. Doucette KE, Weinkauf J, Sumner S, Ens K, Lien D. Treatment of hepatitis C in potential lung transplant candidates. Transplantation 2007;83(12):1652-1655.

26. Mullen JC, Oreopoulos A, Lien DC, Bentley MJ, Modry DL, Stewart K, et al. A Randomized, Controlled Trial of Daclizumab vs. Anti-thymocyte Globulin Induction for Lung Transplantation. J Heart Lung Transplantation 2007;26(5):504-510.

27. Manuel O, Humar A, Preiksaitis J, Doucette K, Shokoples S, Peleg AY, et al. Comparison of the Quantiferon®-TB Gold Assay with Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients with Chronic Liver Disease Awaiting Liver Transplantation. American Journal of Transplant 2007;7(12):2797-2801.

Revised: April 2016

12

28. Pang X, Doucette K, LeBlanc B, Cockfield S, Preiksaitis J. Monitoring of polyoma BK viruria and viremia in renal allograft recipients using quantitative real-time PCR assay: One year prospective study. Journal of Clinical Microbiology 2007;45(11):3568-3573.

29. Doucette K, Dor F, Wilkinson RA, Martin SI, Short G, Huang CA, et al. Gene expression of porcine lymphotrophic herpesvirus-1(PLHV-1) in miniature swine with posttransplant lymphoproliferative disorder. Transplantation 2007;83(1):87-90.

30. Webster D, Ahmed R, Grover P, Chui L, McDonald R, Obarianyk A, et al. Staphylococcus aureus bacteremia in patients receiving pegylated interferon-alpha and ribavirin for chronic hepatitis C virus infection. Journal of Viral Hepatitis 2007;14(8):564-569.

31. Humar A, Doucette K, Kumar D, Pang X, Lien D, Jackson K et al. Assessment of adenovirus infection in adult lung transplant recipients using molecular surveillance. The Journal of Heart and Lung Transplantation 2006;25(12):1441-1446.

32. Lawn SD, Myer L, Wood R, Ivers LC, Kendrick D, Doucette K. Efficacy of antiretroviral therapy in resourcepoor settings: Are outcomes comparable to those in the developed world? [1] (multiple letters). Clin Infect Dis 2005;41(11):16831684.

33. Ivers L, Kendrick D, Doucette K. Efficacy of antiretroviral therapy programs in resources poor settings: A meta-analysis of published literature. Clin Infect Dis 2005;41(2):217-224.

34. Minuk GY, Sun D, Uhanova J, Zhang M, Caouette S, Nicolle LE, et al. Occult hepatitis B virus infection in a North American Community-based population. J Hepatol 2005;42(4):480-485.

35. Dor FJMF, Doucette KE, Mueller NJ, Wilkinson RA, Bajwa JA, McMorrow IM, et al. Posttransplant lymphoproliferative disease after allogeneic transplantation of the spleen in miniature swine. Transplantation 2004;78(2):286-291.

36. Doucette KE and Fishman JA. Nontuberculous mycobacterial infections in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis 2004;38(10):1428-1439.

37. Watt K, Uhanova J, Gong Y, Kaita K, Doucette K, Pettigrew N, et al. Serum Immunoglobulins Predict the Extent of Hepatic Fibrosis in Patients with Chronic Hepatitis C Infections. J Viral Hepat 2004;11(3):251-256.

38. Doucette KE, Bow EJ, Gallbraith P, Rendina A, Binda B, Embil M. Disseminated zygomycosis: a rare cause of infection in patients with hematologic malignancies. J Trauma Inj Infect Crit Care 2003;55(3):568-570.

Revised: April 2016

13

39. Doucette KE and Aoki FY. Oseltamivir: A clinical and pharmacological perspective. Exp Opin Pharmacother 2001;2(10):1671-1683.

40. Embil JM, Hurst L and Doucette K. Photo quiz: Eczema herpeticum. Clin Infect Dis 2001;32(10):1480,1500-1501.

41. Mackowiak PA, Embil JM, Hurst L, Doucette K. Answer to photo quiz. Clin Infect Dis 2001;32(10):1480,15001501.

Guidelines1. Huprikar S, Danziger-Isakov L, Ahn J, Naugler S, Blumber E, Avery RK, et al.

Solid Organ Transplantation From Hepatitis B Virus-Positive Donors: Consensus Guidelines for Recipient Management. American Journal of Transplantation 2015;15(5):1162-1172.

2. Levitsky J and Doucette K. American Society of Transplantation Infectious Disease Guidelines: Viral Hepatitis in Solid Organ Transplantation. American Journal of Transplant 2013;13(SUPPL.4):147-168.

3. Levitsky J and Doucette K. American Society of Transplantation Infectious Disease Guidelines: Viral Hepatitis in Solid Organ Transplant Recipients. American Journal of Transplant 2009;9(Suppl 4):S116-S130.

4. Haddad H, Isaac D, Legare JF, Pflugfelder P, Hendry P, Chan M, et al. Canadian Cardiovascular Society Consensus Conference update on cardiac transplantation 2008: Executive Summary. Canadian Journal of Cardiology. 2009;25(4):197-205.

5. Sherman M, Shafran S, Burak K, Doucette K, Wong W, Girgrah N, et al. Management of hepatitis B: Consensus Guidelines. Canadian Journal of Gastroenterology 2007;21(Suppl C):25C-34C.

6. Sherman M, Shafran S, Burak K, Doucette K, Wong W, Girgrah N, et al. Management of hepatitis C: Consensus Guidelines. Canadian Journal of Gastroenterology 2007;21(Suppl C):5C-24C.

Technical Reports1. Avery R, Clauss H, DanzigerIsakov L, Davis J, Doucette K, Van Duin D et

al. Recommended curriculum for subspecialty training in transplant infectious disease on behalf of the American Society of Transplantation Infectious Diseases Community of Practice Educational Initiatives Working Group. Transplant Infect Dis 2010;12(3):190194.

2. Subramanian A, Humar A, Avery R, Fishman J, Silveira F, Julian K, et al. Recommended Curriculum for Subspecialty Training in Transplant Infectious Diseases On Behalf of the American Society of Transplantation Infectious Diseases Community of Practice Educational Workgroup. Approved by AST Board June, 2009.

Revised: April 2016

14

3. Dryden D, Fassbender K, Doucette K, Tandon P, Mine A, Vandermeer B, et al. Granulocyte colony stimulating factor for the treatment of antiviral-associated neutropenia in patients with hepatitis C. For the Canadian Agency for Drugs and Technologies in Health. October 2008.

Non-Peer Reviewed Manuscripts1. Barama A and Doucette K. Management of the transplant patient: Current

perspectives. Expert opinion: Review of Selected Abstracts: American Transplant congress 2005.

2. Doucette K. Oral infection and systemic disease: Q&A with Karen Doucette. Wellness Options 2005;22:29.

3. Doucette KE and Kaita KDE. C What’s New: The World of Hepatitis C. Can J CME 2002;14(2):153.

Published Abstracts1. Zhang WW, Cheung P, Sidhu M, Brumme Z, Brockman M, Shafran S, et al.

Drug selection facilitates phenotypic examination of integrase inhibitor resistance in a HIV variant mixture. Poster session presented at: The Canadian Association for HIV Research; Winnipeg, Manitoba, May 12-15, 2016. Canadian Journal of Infectious Diseases and Medical Microbiology (awaiting citation)

2. Zelyas N, Smith S, Doucette K. Clostridium difficile infection in solid organ transplant recipients at a tertiary care centre during 2006-2013. Can J Infect Dis Med Microbiology 2015;26(2):e42.

3. Kabbani D, Meeberg G, Cervera C, Doucette K, Preiksaitis J. Vascular Jump Grafts in Liver Transplant: Does it Transmit Cytomegalovirus? Poster session presented at: Canadian Society of Transplantation. Banff, AB, Canada, October 5-10, 2015.

4. Doucette KE, Charles M, Al Dabbagh M and Preiksaitis JK. Epidemiology of Early Post Liver Transplant Infections 2008-12: Time to Reconsider Perioperative Prophylaxis Regimen? Poster session presented at: American Transplant Congress. Philadelphia, PA, May 2-6, 2015. Am J Transplant. 2015;15(suppl 3).

5. Doucette KE, Worton K, Kutsogiannis J and Preiksaitis JK. Utilization of Increased Risk Donors in a Canadian Multi-Organ Transplant Program. Poster session presented at: American Transplant Congress. Philadelphia, PA, May 2-6, 2015. Am J Transplant. 2015;15 (suppl 3).

6. Burton C, Doucette K, Mabilangan C, Preiksaitis J. Hepatitis B and C Serologic Profiles of Organ Donors and Recipients Over a 10 Year Period at a Canadian Transplant Center. Poster session presented at: World Transplant Congress in San Francisco, USA July 26-31, 2014. American Journal of Transplantation 2014;14(S3):693–799.

7. Doucette K and Brar S. Descriptive Analysis of HBV and HCV Positive Patients Referred from a Refugee Clinic. Poster session presented at: AMMI

Revised: April 2016

15

Canada - CACMID Annual Conference in Victoria, BC April 3-5, 2014. Can J Infect Dis Med Microbiol 2014;25 (2)

8. Smith S, Doucette K, Berenger B. Epidemiology and risk factors for blood stream infections in solid organ transplants over a ten-year period. Poster session presented at: ECCMID in Barcelona, Spain May 10-13, 2014.

9. Shafran S, Doucette K, Tang J. A steady increase in proportion of HCV infections due to genotype 3 in the Canadian province of Alberta from 1998 to 2013: Implications for Therapy. Poster session presented at: International Liver Congress™ 2014 in London, UK, April 9-13, 2014. Journal of Hepatology 2014;60(1):S307.

10. Congly SE, Rezaeeaval M, Doucette K, Osiowy C, Lee SS, Myers RP, et al. Utility of Quantitative Hepatitis B Surface Antigen Titres in the Classification of Chronic Hepatitis B (CHB) Disease Phases. Poster session presented at: Canadian Digestive Diseases Week (CDDW) in Toronto, Ontario February 7-11, 2014.

11. Peters A, Iafolla M, Akinwumi M, Mabilangan C, Elliott L, Doucette K, et al. Epidemiology of Post-Transplant Lymphoproliferative Disorders Following Solid Organ Transplant In a Major Canadian Transplant Centre. Poster session presented at: American Society of Hematology AGM (poster). December 7-10, 2013; New Orleans, LA. Blood 2013;122(21).

12. Peters A, Owen CJ, Doucette K, Preiksaitis J. Lymphopenia and EBER-Negativity Predict Poor Survival in Post-Transplant Lymphoproliferative Disorder (PTLD) Treated in the Rituximab Era. Am J Trans 2012;12(Suppl 3):352.

13. Preiksaitis J, Silva M, Al-Kaabi M, Yashu Coe J, Cockfield S, Doucette K. Successful Treatment of Central Nervous System Posttransplant Lymphoproliferative Disorder Using Rituximab and Reduction in Immunosuppression Alone. Am J Trans 2012;12(Suppl 3):353.

14. Preiksaitis J, Mabilangan C, Pang X, Lee B, Doucette K. Risk of Post-Transplant Lymphoproliferative Disorders (PTLD) in Children and Adults with Chronic Epstein-Barr Virus Load Phenotype (CVLP). Am J Trans 2012; 12(Suppl 3):353.

15. Doucette KE, Weinkauf J, Jackson K, Lien D. Survival Following Lung Transplantation Is Not Impacted by Hepatitis C Infection. Am J Trans 2012; 12(Suppl 3):472-473.

16. Haider S, Laverdiere M, Rotstein C, Husain S, Doucette K, Power M, et al. Liver Safety of Posaconazole in Early Salvage Therapy for Invasive Fungal Infections Caused by Molds and Yeasts. Poster session presented at: Infectious Diseases Society of America (IDSA). May 2012.

17. Peters A and Doucette K. Lymphopenia and EBER-Negativity Predict Poor Survival in Patients with Post-Transplant Lymphoproliferative Disorder (PTLD) Treated in the Rituximab Era. Poster session presented at: 53rd Annual Meeting

Revised: April 2016

16

of The American Society of Hematology (ASH); December 10- 13, 2011; San Diego, CA. Blood 2011;188(21).

18. Pittman C, Plitt S, Birse E, Doucette K, Romanowski B, Cooper R, et al. Prevalence, correlates, and outcomes of HIV and Hepatitis B Virus co-infected patients in Northern Alberta. Poster session presented at: Honouring our history, embracing our diversity. Poster session presented at: 20th Annual Canadian Conference on HIV/AIDS Research (CAHR); 2011 Apr 15; Toronto, ON.

19. Saxinger L, Fryters S, Doucette K. Developing an Antifungal Prophylaxis Algorithm in High Risk Neutropenic Patients Using Surveillance of Local Invasive Fungal Disease Prevalence and Modeling Based on Published Data. Poster session presented at: The Association of Medical Microbiology and Infectious Diseases Canada (AMMI Canada) annual meeting. Montreal PQ – April 6-April 8, 2011. Can J Infect Dis Med Microbiol 2011;22(Suppl A).

20. Doucette K, Venner J, Preiksaitis J. Comparison of CMV Antigenemia (Ag)

and PCR during Pre-Emptive Therapy Monitoring and Treatment of CMV Disease. American Journal of Transplantation 2010;10(Suppl 4).

21. Doucette K, Dicken B, Bigam D, Preiksaitis J. Epstein-Barr Virus Viral Load monitoring in High Risk, EBV Donor Seropositive (D+), Recipient Seronegative (R-(, Adult and Pediatric Solid Organ Transplant (SOT) Patients Decreases Early Posttransplant Lymphoproliferative Disorder (PTLD). American Journal of Transplantation 2010;10(Suppl 4).

22. Hu J, Doucette K, Hartling L, Tjosvold L, Robinson J. Treatment of Hepatitis C in Children: A Systematic Review Submitted to Clinical Infectious Diseases. Can J Infect Dis Med Microbiol 2010;21(Suppl A).

23. Cooper C, Robert J, Feinman VS, Elkashab M, Anderson FH, Scully LJ, et al. Outcomes of a Large, Inclusive Population Based Hepatitis C Treatment Program are Similar to Randomized Controlled Trials: Interim Results of the Canadian Redipen Program. Hepatology 2009;50(4):703.

24. Kumar D, Husain S, Moussa G, Doucette K, Manuel O, Weinkauf J, et al. A Prospective Molecular Surveillance Study Evaluating the Clinical Impact of Community Acquired Respiratory Viruses in Lung Transplant Recipients. American Journal of Transplantation 2008;8(2):231.

25. Doucette K, Kumar D, Chow A, Tyrell G, Cobos I, Humar A, et al. Comparison of the Quantiferon-TB Gold to Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Renal Transplant Candidates. American Journal of Transplantation 2008;8(2):231.

26. Manuel O, Pang X, Humar A, Kumar D, Doucette K, Preiksaitis JK. An Assessment of Donor to Recipient Transmission Patterns of Human Cytomegalovirus by Analyzing Viral Genomic Variants. American Journal of Transplantation 2008;8(2):232.

Revised: April 2016

17

27. Kumar D, Chernenko S, Moussa G, Preiksaitis J, Doucette K, Manuel O, et al. A Prospective Study of CD8+ T-Cell Mediated Immunity to Cytomegalovirus (CMV) as a Predictor CMV Disease. American Journal of Transplantation 2008;8(2):266.

28. Doucette K, Robson V, Kunimoto D, Division of Infectious Diseases; Hepatitis Support Program, University of Alberta, Edmonton, AB. Improving Access to Care by Allowing Self Referral to a Hepatitis C Clinic. Can J. Gastroenterology 2008;8(2):266.

29. Doucette K, Weinkauf J, Sumner S, Ens K, Lien D. Treatment of hepatitis C in potential lung transplant candidates. Transplantation 2007;8(1):86-90.

30. Pang XL, Doucette K, LeBlanc B, Cockfield SM, Preiksaitis JK. Monitoring of Polyomavirus BK Virus Viruria and Viremia in Renal Allograft Recipients by Use of a quantitative Real-Time PCR Assay: One-Year Prospective Study. J Clin Microbiology 2007;45(11):3568-3573.

31. Doucette K, Jackson K, Taskinen H, Weinkauf J, Stewart K, Mullen J, et al. Similar survival of hepatitis C positive and hepatitis C negative recipients following lung transplantation. American Journal of Transplantation 2007;7(Supp 2):502.

32. Manuel O, Humar A, Preiksaitis J, Doucette K, Shokoples S, Peleg AY, et al. Comparison of the Quantiferon®-TB Gold Assay with Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients with Chronic Liver Disease Awaiting Liver Transplantation. American Journal of Transplantation 2007;7(12):2797–2801.

33. Saxinger L, Parimi S, Doucette K, Fryters S, Gray M. Antifungal utilization and adherence with guidelines in treating fungal infections in two tertiary care hospitals, 2002-2006. Can J Inf Dis 2007;18(1):40.

34. Doucette KE, Jackson KB, Taskinen HA, Weinkauf JG, Stewart KC, Mullen J, et al. Similar Survival of Hepatitis C Positive and Hepatitis C Negative Recipients Following Lung Transplantation. American Journal of Transplantation 2007;7(supp 2):502.

35. Doucette K, Weinkauf J, Sumner S, Ens K, Lien D. Treatment of Hepatitis C in patients awaiting lung transplantation. Poster session presented at: World Transplant Congress Poster Presentation, July, 2006. American Journal of Transplantation August 2006;6(suppl 12):731.

36. Dicken BJ, Bigam DL, Fenton J, Pang XL, Preiksaitis JK, Doucette KE. Minimizing post transplant lymphoproliferative disease through Epstein Barr Virus monitoring. American Journal of Transplantation 2006;6(suppl 12):869-870.

Revised: April 2016

18

37. Pang XL, Doucette K, LeBlanc B, Cockfield SM, Preiksaitis JK. Monitoring BK virus in renal allograft recipients using quantitative PCR. Poster session presented at: European Society for Clinical Virology. (Birmingham, U.K. September, 2006). Journal of Clinical Virology 2006; 36(supp 2):S44.

38. Doucette K, Weinkauf J, Lien D. Treatment of hepatitis C in lung transplant candidates. Oral session presented at: Association of Medical Microbiology and Infectious Diseases Annual Meeting. Canadian Journal of Infectious Diseases & Medical Microbiology 2006;17(1):46.

39. Webster D, Ahmed R, Grover P, Chui L, McDonald RR, Obarianyk A, et al. Staphylococcus aureus bacteremia in patients receiving pegylated interferon alfa and ribavirin for chronic hepatitis C infection. Oral session presented at: Association of Medical Microbiology and Infectious Diseases Annual Meeting. Canadian Journal of Infectious Diseases & Medical Microbiology 2006;17(1):46.

40. Weinkauf JG, Lien DC, Damant R, Skjodt NM, Doucette K, Jackson KB, et al. Should lung transplantation be offered to previous intravenous drug users with Talc Lung Granulomatosis? American Journal of Transplantation 2006;6(supp12):730-731.

41. Humar A, Doucette K, Kumar D, Pang X, Lien D, Jackson K, et al. An assessment of adenovirus infection in adult lung transplant recipients using molecular surveillance methods. Poster session presented at: American Transplant Congress, Seattle, WA, May 2005. American Journal of Transplantation 2005;5(11):385.

42. Pang XL, Doucette K, Cockfield S, LeBlanc B, and Preiksaitis J. A novel real-time PCR assay for the quantitation of polyoma BK virus in renal allograft recipients. Poster session presented at: Pan American Society for Clinical Virology Symposium May 8 – 11, 2005, Clearwater FL, USA.

43. Dor FJMF, Doucette KE, Mueller NJ, Wilkinson RA, Bajwa JA, McMorrow IM, et al. Posttransplant lymphoproliferative disease after allogeneic spleen transplantation in miniature swine. Poster session presented at: American Transplant Congress, Boston MA, USA 2004. American Journal of Transplantation 2004;4(Suppl 8):462.

44. Doucette K, Zhang M, Hawkins K, Kaita KD, Minuk GY. Residual hepatitis B infection. Hepatology 2002;36(4):367A.

45. Doucette KE and Evans GA. Outpatient parenteral antibiotic therapy of endocarditis: A cost minimization analysis. Can J Inf Dis 1999;10(supp D):91D.

Unpublished Abstracts1. Akbar S and Doucette K. Herpes Simplex Virus (HSV) Reactivation Following

Renal and Liver Transplantation under Modern Immunosuppression. Canadian Society of Transplantation March 2007.

Revised: April 2016

19

2.Hobbs D, Andonov A, Campbell P, Doucette K, Lee B, Taylor G. Pseudo Healthcare

Transmission of HCV in A Renal Transplantation Patient. Poster session presented at: Community and Hospital Infection Control Association - Canada (CHICA) Annual Meeting. June 2007.

Book Chapters1. Remington L and Doucette K. Prosthetic valve Endocarditis and Cardiovascular

Device Related Infections. Chan KL, Embil JM, editors. Endocarditis: Diagnosis and Management (chapter 11). Springer-Verlag London Limited, 2016; 311-331.

2. Doucette KE and Fishman JA. Infections in the Immunocompromised Host. Civetta, Taylor, and Kirby’s Critical Care, 5th Edition. Lippincott Williams & Wilkins. In press 2016;

3. Cooper R and Doucette K. Tuberculosis: Epidemiology, Prevention, Diagnosis, and Management (Chapter 131). Fishman’s Pulmonary Diseases and Disorders, 5th Edition. McGraw-Hill. Editors, Drs. Michael A. Grippi, Jack A. Elias, Jay A. Fishman, Allan I. Pack and Robert M. Senior. 2015:2012-31.

4. Doucette KE and Fishman JA. Infections in the Immunocompromised Host. Civetta, Taylor, and Kirby’s Critical Care, 4th Edition. Lippincott Williams & Wilkins, 2008;(chapter 115):1717-31.

5. Sligl W and Doucette K. Prosthetic valve and device related endocarditis. Chan KL, Embil JM, editors. Endocarditis: Diagnosis and Management. Springer-Verlag London Limited, 2006;(chapter 4):201-13.

TEACHING (see Teaching CV for details)Physicianship Preceptor - Clinical Skills Teaching Year 1 and 2 medical studenst (2015-present

Gilbert Scholars – Teaching clinical skills to year 2 medical students (2011-2014).

Program Director Transplant Infectious Diseases, University of Alberta since January 2008.

Clinical Teaching of medical students and residents on Infectious Diseases Consult Service (2 weeks per year). University of Alberta 2004 – present.

Clinical Teaching of subspecialty residents and Transplant ID Fellow on Transplant Infectious Diseases Consult Service (16-18 weeks per year). University of Alberta 2004 – present.

Infectious Diseases Ambulatory Clinic teaching (Residents, Medical Students). University of Alberta 2004 – present.

Revised: April 2016

20

Undergraduate problem-based learning (Discovery Learning) facilitator. University of Alberta 2004 – present.

Supervisor of student and resident research projects

2016 – Daniel Freidman R2 in Medicine2015 – Leah Remington R5 in Infectious Diseases2014 – Marthe Charles R4 Internal medicine2014 - Nathan Zelyas R4 in Medical Microbiology2013 – Byron Berenger R3 in Medical Microbiology2013 – Sandeep Brar R2 in Internal Medicine2013 - Kevin Wen – R6 Renal Transplant Fellow2012-2013 - Mona Al-Dabbagh – R6 in Transplant Infectious Diseases2012-2013 – Catherine Burton - R6 in Transplant Infectious Diseases2008-2009 - Leyla Asadi - R1 in Medicine 2006 - Jeffery Venner – BSc student2006 - Sunil Parimi (co-supervisor) – Medicine year 12005-2006 – Shafiq Akbar – R2 in Medicine2005-2006 – Bryan Dicken – R5 in Surgery2004-2005 – Rabia Ahmed – R5 in Infectious Diseases

Lectures and Interactive case-based sessions for resident academic half-day (infectious diseases, general internal medicine, nephrology, dermatology, critical care and pulmonary). University of Alberta 2004 – present.

Continuing Medical Education – lectures and interactive sessions for faculty, community physicians and allied health professionals: ~ 8-9 sessions/year.

EDUCATIONAL MATERIALS DEVELOPMENT Curriculum Development2014 As member of the RCPSC Solid Organ Transplant Area of Focused

Competence Working Group significant contributions were made to the development of the following documents: Competency Training Requirements AFC Standards of Accreditation Competency Portfolio for the Diploma in SOT Practice Eligibility Route Competency Portfolio.

2013 Viral Hepatitis Rotation – University of Alberta Infectious Diseases Subspecialty Training Program.Rotation for ID residents to increase their exposure patients with hepatitis B and C to gain competence in management of these patients with an ultimate goal to increase capacity to provide care for these patients in Canada. The University of Alberta Infectious Diseases Division has a unique ability in Canada to provide this focused training. The rotation has now been made a mandatory 2 week rotation for ID SSR's and we have offered it as an elective to ID trainees in Canada (with 3 requests in the 4 months since established). The rotation includes:

Revised: April 2016

21

7-8 half day clinics per week, 1-2 sessions with the nurses, 2 case-based interactive one on one teaching sessions with a faculty member, and 1 session focusing on virology (done by a virologist).

A workbook to supplement education on topics that may be inadequately covered in a 2 week clinic block (e.g. pregnancy, acute HBV/HCV, management of cirrhosis). This is given to the resident at the start of the rotation to work on during and then reviewed and discussed with me at the end of the rotation.

2008 – 2009 Curriculum for Transplant Infectious Diseases Fellowship.Full curriculum (objectives, specific descriptions of rotations, outpatient clinic schedule, educational and clinical rounds) developed. This is a unique training program in Canada. Our first fellow entered the program in September, 2008 and we have had 1 or 2 fellows each year since. Many of our trainees have gone on to academic positions and success documented by publications and awards. The curriculum document has served as one of the models to develop a suggested curriculum for training Transplant ID physicians through the American Society of Transplantation Infectious Diseases Community of Practice.

2008 – 2009 Revised objectives/format of Infectious Diseases/Medical Microbiology Journal Club and developed a template for article review and critical appraisal for the presenting residents. Revisions to the format of the journal club were made to re-focus the objectives on improving critical appraisal and a basic understanding of statistics and epidemiologic methods.

2007 – 2008 Orientation Package: Transplant Infectious Diseases Rotation (for Infectious Diseases Subspecialty Residents).

2007 – 2008 Transplant Infectious Diseases Overview (handout) for rotating residents/students on Infectious Diseases consult service.

OTHER PROFESSIONAL ACTIVITIESProfessional Development 2013-2014 Academic Leadership Development Program

This is a comprehensive learning program sponsored by the Office of the Provost and VP (Academic) in partnership with the Faculty of Medicine & Dentistry, and Organizational Learning and Effectiveness.

2013 Department of Medicine Mentorship Workshop

2013 The Transplantation Society Education AcademyWorld class leaders are engaged to provide a series of 12 webinars over the year on key topics in medical education.

Revised: April 2016

22

10/2013 Canada GCP (Good Clinical Practices)Online course through NATRAC.

10/2010 Teaching Enhancement SeriesContext and Learning Part 2Centre for Teaching and LearningUniversity of Alberta

Teaching Enhancement Series OutcomesCentre for Teaching and LearningUniversity of Alberta

Teaching Enhancement SeriesContext and Learning Part 1Centre for Teaching and LearningUniversity of Alberta

09/2010 Teaching Enhancement SeriesConcept MappingCentre for Teaching and LearningUniversity of Alberta

09/2009 Investigator Training Program (ITP)

03/2008 Problem Based Learning Module For Discovery LearningDivision of Studies in Medical EducationUniversity of Alberta

04/2007 Introductory ModuleProblem Based LearningDivision of Studies in Medical Education University of Alberta

03/2007 Promotions WorkshopDepartment of Medicine and Career Development ProgramUniversity of Alberta

05/2005 Building Research Capacity Workshop Series: Applying for Grants Workshop Faculty of Medicine and Dentistry /HRS Staff Learning and Development/Research Services Office

Formal Mentoring2012-current - Dr. Stephanie Smith, Associate Professor.

Clinical Protocol Development The following protocols were developed to assist transplant physicians and coordinators in the clinical management of transplant recipients and to act as a learning tool for trainees in all areas of transplant medicine. Protocols can be Revised: April 2016

23

found on the Capital Health Intranet website at: www.intranet2.capitalhealth.ca/Transplant Services/infectious%20Disease.html

2015 Management of Respiratory Infections in Patients with Cystic Fibrosis Undergoing Lung Transplantation - Alberta Transplant Protocols

2014 Increased Risk Donor Protocol Alberta Transplant Protocols

2014 Perioperative Prophylaxis in Liver Transplant Alberta Transplant Protocols

2014 Antimicrobial prophylaxis and dental procedures post transplantation

2013 Liver Transplantation in HIV-Infected Patients

2013 Antifungal Prophylaxis in Liver Transplantation

2013 Utilization of Hepatitis B surface antigen positive donors

2010 Hepatitis B in donors and recipients of non-hepatic solid organ transplant

2009 Antifungal Prophylaxis Post Lung Transplant

2008 Antimalarial Prophylaxis and Immunosuppressive Drug Interactions

2008 Epstein Barr Virus and Posttransplant Lymphoproliferative Disease (revision)

2005 Interpretation and Management of Tuberculin Skin Test

2005 Epstein Barr Virus and Posttransplant Lymphoproliferative Disease

2005 Management of Donor and Recipient HBV Serology Results in Non-Hepatic Organ Recipients

2005 Guidelines for Immunization of Immunocompromised Hosts (In conjunction with Alberta Health and Wellness)

2004 Overview: Infection in Solid Organ Transplant Recipients

2004 General Medical Evaluation Pretransplant

2004 Recipient Pre-transplant Screening

2004 Donor Screening

2004 Interpretation and Response to Positive Donor Screening Results

2004 Prevention and Treatment of CMV in Solid Organ Transplantation (SOT)Revised: April 2016

24

EXAMINER2008-2015 Appointed to:

Royal College of Physicians and Surgeons of Canada Infectious Diseases Examination Board

2004-current Resident (R1-R4) In-Training Oral Examination

2007-2008 OSCE Examiner: Year 4 Medical Students

2005-2006 OSCE Examiner Year 4 Medical Students

2004-2005 OSCE Examiner: Year 3 Medical Students

2004-2005 OSCE Examiner: Year 4 Medical Students

2001 Medical Council of Canada ExaminerQualifying Examination Part II

COMMITTEES

2015-Present Member, Provincial Laboratory for Public Health Search and Selection Committee

2015-Present Member, Department of Medicine Steering Committee

2015-Present Member, Edmonton Zone Clinical Department of Medicine Executive Committee

2014-2015 Member, Department of Medicine Ambulatory Care Working Group

2014-Present Member, Canadian Society of Transplantation Education Committee

2012-Present Member, Academic Appeals CommitteeUniversity of Alberta

2012-Present Member, Royal College of Physicians and Surgeons of Canada

Solid Organ Transplant Area of Focused Competence Committee

2012-Present Member, Alberta Transplant Institute Education Committee

2012-Present Member, 3A Edmonton Clinic Management Committee

2008-2013 Member, American Society of Transplantation InfectiousDiseases Community of Practice Education Committee

Revised: April 2016

25

2007-Present Member, Infectious Diseases Residency Training Committee

University of Alberta

2006-Present Member, Alberta Expert Review Panel for Blood Borne Infections in Health Care WorkersUnder Ministerial Order, Alberta Health and Wellness

2006-Present Member, ID Clinical Trials Management

2005-Present Member, HOPE (Organ Procurement Organization) Advisory Committee

Alberta Health Services Edmonton, Alberta, Canada

2005-2011 Member, Regional Antimicrobial Stewardship Committee Alberta Health ServicesEdmonton, Alberta, Canada

2007-2010 Member, Medical and Scientific Advisory Committee to the Canadian Hemophilia Society

2008-2009 Member, Medicine Clinics Patient Care CommitteeAlberta Health Services and Department of Medicine, University

of Alberta

June 2008 Department of Medicine Infectious Diseases Director Search & Selection Committee

2006-2008 Member at Large, Executive Committee, American Society of Transplantation Infectious Diseases Community of Practice

1999-2001 Infection Control CommitteeHealth Sciences CenterWinnipeg, Manitoba, Canada

Revised: April 2016

26